The Machado-Joseph disease-associated form of ataxin-3 impacts dynamics of clathrin-coated pits.

Cell Biol Int

Department of Pharmacology, University of Michigan Medical School, 2301 MSRB III, 1150 W. Medical Center Dr., Ann Arbor, Michigan, 48109, USA.

Published: May 2020

Expansion above a certain threshold in the polyglutamine (polyQ) tract of ataxin-3 is the main cause of neurodegeneration in Machado-Joseph disease. Ataxin-3 contains an N-terminal catalytic domain, called Josephin domain, and a highly aggregation-prone C-terminal domain containing the polyQ tract. Recent work has shown that protein aggregation inhibits clathrin-mediated endocytosis (CME). However, the effects of polyQ expansion in ataxin-3 on CME have not been investigated. We hypothesize that the expansion of the polyQ tract in ataxin-3 could impact CME. Here, we report that both the wild-type and the expanded ataxin-3 reduce transferrin internalization and expanded ataxin-3 impacts dynamics of clathrin-coated pits (CCPs) by reducing CCP nucleation and increasing short-lived abortive CCPs. Since endocytosis plays a central role in regulating receptor uptake and cargo release, our work highlights a potential mechanism linking protein aggregation to cellular dysregulation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbin.11312DOI Listing

Publication Analysis

Top Keywords

polyq tract
12
ataxin-3 impacts
8
impacts dynamics
8
dynamics clathrin-coated
8
clathrin-coated pits
8
tract ataxin-3
8
protein aggregation
8
expanded ataxin-3
8
ataxin-3
7
machado-joseph disease-associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!